Scarica l'app Stockscreener
74.21
2.30%
-1.75
Dopo l'orario di chiusura:
74.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Ani Pharmaceuticals Inc Borsa (ANIP) Ultime notizie
Travel Stocks: Will ANI Pharmaceuticals Inc stock go up in YEAR2026 Big Picture & Real-Time Stock Entry Alerts - baoquankhu1.vn
ANI Pharmaceuticals: Worthy Of A Position - seekingalpha.com
A Look At ANI Pharmaceuticals (ANIP) Valuation After Mixed Short Term Share Price Moves - Sahm
Why ANI Pharmaceuticals (ANIP) Stands Out as a Leading Long-Term Growth Stock - Bitget
Why ANI Pharmaceuticals (ANIP) is a Top Growth Stock for the Long-Term - finance.yahoo.com
ANI Pharmaceuticals, Inc. (ANIP) Stock forecasts - Yahoo Finance UK
ANI Pharmaceuticals, Inc. (ANIP) Stock Forecasts - Yahoo! Finance Canada
AGIO Rises on Mitapivat Progress Toward Accelerated Approval in SCD - TradingView
Is ANIP Undervalued? How to Read Its 9.3x Forward P/E - TradingView
ANI Pharmaceuticals 2026 Watchlist: Gout Sales Force and Rare Disease - finance.yahoo.com
Ultragenyx Pharmaceutical Announces FDA Acceptance of UX016 IND - TradingView
Volume Recap: Can ANI Pharmaceuticals Inc beat the S P 5002026 Spike Watch & Consistent Return Investment Signals - baoquankhu1.vn
SG Americas Securities LLC Buys 73,334 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANIP Stock Price, Quote & Chart | ANI PHARMACEUTICALS INC (NASDAQ:ANIP) - ChartMill
Price Action: Why is ANI Pharmaceuticals Inc stock going upWeekly Market Report & Daily Entry Point Trade Alerts - baoquankhu1.vn
RCKT Stock Down Despite FDA Nod to Gene Therapy in Rare Disease - TradingView
Assenagon Asset Management S.A. Has $7.09 Million Stock Position in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 - AOL.com
ANI Pharma Insider Sells 4,772 Shares as Revenue Hits $883 Million in 2025 - The Motley Fool
Is Record 2025 Sales And 2026 Guidance Past US$1 Billion Altering The Investment Case For ANI Pharmaceuticals (ANIP)? - Sahm
Vanguard (ANIP) amendment: reports 0 shares after Jan 12, 2026 realignment - Stock Titan
How The ANI Pharmaceuticals (ANIP) Investment Narrative Is Shifting With Updated Analyst Assumptions - Yahoo Finance
IBRX Stock Slides on FDA Warning Over Misleading Cancer Drug Claims - TradingView
Risk Analysis: Will ANI Pharmaceuticals Inc announce a stock splitTrade Performance Summary & Weekly Breakout Opportunity Watchlist - baoquankhu1.vn
INSM Stock Gains After Arikayce Hits Goal in Label Expansion Study - TradingView
FDA Grants Priority Tag to Ionis' NDA for Alexander Disease Drug - TradingView
GSK's Risvutatug Rezetecan Gets Japan Orphan Drug Tag for Lung Cancer - TradingView
Oliver Luxxe Assets LLC Invests $1.82 Million in ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
BioSante Pharmaceuticals and ANI Pharmaceuticals Announce Completion of Merger - Yahoo
ANI Pharmaceuticals, Inc. (NASDAQ:ANIP) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
ANI Pharmaceuticals Expands Ophthalmology Reach As Valuation Signals Upside Potential - Yahoo Finance
Assessing ANI Pharmaceuticals (ANIP) Valuation After Rare Disease Momentum And Alimera Acquisition - Sahm
Puma Biotechnology Stock Declines More Than 9% in a Month: Here's Why - TradingView
Agios Pharmaceuticals Stock Declines 23% in 6 Months: Here's Why - TradingView
Guggenheim Remains a Buy on ANI Pharmaceuticals (ANIP) - The Globe and Mail
ANIP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI
Is ANI Pharmaceuticals (ANIP) Pullback Hiding A Contradiction In Its Valuation Story - simplywall.st
EPS Watch: Can ANI Pharmaceuticals Inc lead its sector in growthQuarterly Earnings Summary & Fast Entry Momentum Alerts - baoquankhu1.vn
COGT Rise as FDA Accepts Bezuclastinib NDA in Non-Advanced SM - tradingview.com
ANIP PE Ratio & Valuation, Is ANIP Overvalued - Intellectia AI
IBRX Stock Jumps on Progress in NK Cell Therapy Production - TradingView
Zacks Industry Outlook Features Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals, and Liquidia - Bitget
Zacks Industry Outlook Highlights Terns Pharmaceuticals, ADMA Biologics, ANI Pharmaceuticals and Liquidia - The Globe and Mail
ANI Pharmaceuticals Insiders Unload $584K in Shares Amid 18-Month Selling Streak - AlphaStreet
234,219 Shares in ANI Pharmaceuticals, Inc. $ANIP Acquired by Divisadero Street Capital Management LP - MarketBeat
Apis Capital Advisors LLC Purchases 36,000 Shares of ANI Pharmaceuticals, Inc. $ANIP - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) Stock Rating Lowered by Wall Street Zen - MarketBeat
Ani Pharmaceuticals SVP Cook sells $36k in stock - Investing.com
Ani Pharmaceuticals SVP Cook sells $36k in stock By Investing.com - Investing.com South Africa
Meredith Cook Sells 500 Shares of ANI Pharmaceuticals (NASDAQ:ANIP) Stock - MarketBeat
Insider Selling: ANI Pharmaceuticals (NASDAQ:ANIP) Insider Sells 3,162 Shares of Stock - MarketBeat
ANI Pharmaceuticals (NASDAQ:ANIP) SVP Thomas Andrew Rowland Sells 4,772 Shares - MarketBeat
Ani pharmaceuticals SVP Rowland sells $357k in stock By Investing.com - Investing.com South Africa
Ani pharmaceuticals SVP Rowland sells $357k in stock - Investing.com
[Form 4] ANI PHARMACEUTICALS INC Insider Trading Activity - Stock Titan
ANI Pharmaceuticals (ANIP) legal chief sells 500 shares under 10b5-1 plan - Stock Titan
Allogene Therapeutics Posts Narrower-Than-Expected Loss in Q4 - TradingView
ANI Pharmaceuticals, Inc. $ANIP Stock Position Reduced by Kennedy Capital Management LLC - MarketBeat
Sizing Up ANI Pharmaceuticals (ANIP) After Recent Share Price Pullback - Yahoo Finance
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):